SCHEMBL31099650

SCHEMBL31099650

CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCC(N5CCN(Cc6ccc(C7CCC(=O)NC7=O)c(F)c6)CC5)CC4)cc3)c2C1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 15/20 0.57
▸ AURKB Q96GD4 8/20 0.57
▸ NTRK1 P04629 5/20 0.57
▸ CDK2 P24941 5/20 0.57
▸ ABL1 P00519 4/20 0.57
▸ RET P07949 3/20 0.57
▸ FGFR1 P11362 3/20 0.57
▸ LIMK1 P53667 3/20 0.57
▸ BCR P11274 3/20 0.57
▸ FLT3 P36888 3/20 0.57
▸ PLK4 O00444 2/20 0.57
▸ JAK2 O60674 2/20 0.57
▸ MAP4K4 O95819 2/20 0.57
▸ LCK P06239 2/20 0.57
▸ FYN P06241 2/20 0.57
▸ FES P07332 2/20 0.57
▸ LYN P07948 2/20 0.57
▸ SRC P12931 2/20 0.57
▸ PHKG2 P15735 2/20 0.57
▸ FER P16591 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31100685 0.97 AURKA (0.61) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL31101675 0.92 AURKA (0.60) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL31099960 0.91 AURKA (0.61) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL31100814 0.90 AURKA (0.59) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL31102326 0.90 AURKA (0.61) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL31101436 0.89 AURKA (0.64) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL31103127 0.88 AURKA (0.57) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL31100451 0.88 AURKA (0.60) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL25276226 0.87 AURKA (0.57) AURKAAURKBNTRK1CDK2ABL1
SCHEMBL25276225 0.87 AURKA (0.57) AURKAAURKBNTRK1CDK2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4678638-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-01-14 — — EP claimed
WO-2024188209-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-09-19 — — WO claimed
Send feedback